Org 5594565169Economic activity was not specified by tax authority · NACE 0000Est. 20230 employees
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
9.9%
Financial strength
Net profit 2024
SEK 0
+100% vs 2023
EBITDA — year on yearSEK millionsKey figuresAnnual report 2024
Revenue
SEK 0
—
EBITDA
—
—
Net profit
SEK 0
+100%
Total assets
SEK 230K
-16%
Equity
SEK 23K
-92%
Employees
0
—
Company information
Legal name
DendriNova Therapeutics AB
Org number
5594565169
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
10 november 2023
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska utveckla nya metoder för effektiv vaccinering mot olika sjukdomstillstånd inkluderande cancer och infektioner samt därmed förenlig verksamhet.
Contact
Address
Email
ggk.riesbeck@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.